Table 2.
CDSS version 0.9 (n=1,176) | CDSS version 1.0 (n=1,333) | |
---|---|---|
Group 1: HDF drug |
26.1% |
31.7% |
Group 2: Pharmaceutical equivalent |
45.2% |
40.7% |
Group 3: Pharmaceutical alternative |
14.0% |
12.2% |
Group 4: Therapeutic equivalent |
8.3% |
7.0% |
Σ: CDSS-switch |
93.6%* |
91.6% |
Group 5: No CDSS-switch | 6.5%* | 8.4% |
*>100.0% due to rounding.
CDSS: Clinical decision support system, HDF: Hospital drug formulary.